Product Program year 2019 Source: CMS Open Payments

Feiba

Biological Hematology

NDC 64193-423-02

Open in the dashboard

General payments

$12,462

31 payments

Research payments

$77,170

2 payments

Through program year 2019, $12,462 in general payments and $77,170 in research payments were reported against Feiba (Hematology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2019 General $12,462 31
2019 Research $77,170 2

Breakdown

Who paid General payments · program year 2019
  1. Shire North American Group Inc $12,462 31 payments
Top recipients General payments · program year 2019
  1. Fernando Corrales-Medina Pediatric Hematology-Oncology · Miami, FL $9,666 78% · 6 payments
  2. Steven Kang Blood Banking & Transfusion Medicine · Brooklyn, NY $470 4% · 3 payments
  3. Vinod Balasa Pediatric Hematology-Oncology · Madera, CA $397 3% · 3 payments
  4. Tammuella Chrisentery-Singleton Pediatric Hematology-Oncology · New Orleans, LA $213 2% · 2 payments
  5. Valerie Cortes-Sanchez Internal Medicine · San Juan, PR $153 1% · 1 payment

The top 5 of 21 recipients; each share is of general payments naming this product in 2019.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2019
  1. Pediatric Hematology-Oncology Pediatrics $10,647 86% · 6 practitioners
  2. Blood Banking & Transfusion Medicine Pathology $470 4% · 1 practitioner
  3. Internal Medicine $395 3% · 3 practitioners
  4. Hematology & Oncology Internal Medicine $161 1% · 2 practitioners
  5. Nephrology Internal Medicine $140 1% · 2 practitioners

The top 5 of 11 specialties; each share is of general payments naming this product to practitioners with a specialty in 2019. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2019
  1. Florida $9,704 78% · 3 recipients
  2. California $1,248 10% · 8 recipients
  3. New York $512 4% · 3 recipients
  4. Louisiana $354 3% · 2 recipients
  5. Texas $250 2% · 2 recipients

The top 5 of 8 states; each share is of general payments naming this product in 2019 where a state was reported.

The top 25 states, free in the app

31 general · 2 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2019

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record